Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02199964 · ClinicalTrials.gov registry record · NA
The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02199964 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 4 participants.
The verdict
NCT02199964, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will test that hypothesis that topical administration of the FDA approved immunomodulatory agent cyclosporin A emulsion will minimize irritation and ocular surface disease that results from a short term low humidity environmental stress
Interventions
- DRUG Cyclosporin 0.05% emulsion
- DRUG Endura, Refresh artificial tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02199964
The ClinicalTrials.gov registry entry for NCT02199964 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cyclosporin 0.05% emulsion is the first listed.
NCT02199964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02199964 about?
NCT02199964 is a clinical study titled "The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface". This study will test that hypothesis that topical administration of the FDA approved immunomodulatory agent cyclosporin A emulsion will minimize irritation and ocular surface disease that results from a short term low humidity environmental stress
What is the current status of trial NCT02199964?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02199964?
The interventions under investigation include: Cyclosporin 0.05% emulsion (DRUG), Endura, Refresh artificial tears (DRUG).
Who is sponsoring clinical trial NCT02199964?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.